Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 116

1.

Human cytomegalovirus pUL79 is an elongation factor of RNA polymerase II for viral gene transcription.

Perng YC, Campbell JA, Lenschow DJ, Yu D.

PLoS Pathog. 2014 Aug 28;10(8):e1004350. doi: 10.1371/journal.ppat.1004350. eCollection 2014 Aug.

2.

Murine cytomegalovirus protein pM92 is a conserved regulator of viral late gene expression.

Chapa TJ, Perng YC, French AR, Yu D.

J Virol. 2014 Jan;88(1):131-42. doi: 10.1128/JVI.02684-13. Epub 2013 Oct 16.

3.

Elongin B-mediated epigenetic alteration of viral chromatin correlates with efficient human cytomegalovirus gene expression and replication.

Hwang J, Saffert RT, Kalejta RF.

MBio. 2011 Mar 29;2(2):e00023-11. doi: 10.1128/mBio.00023-11. Print 2011.

5.

Occupancy of RNA Polymerase II Phosphorylated on Serine 5 (RNAP S5P) and RNAP S2P on Varicella-Zoster Virus Genes 9, 51, and 66 Is Independent of Transcript Abundance and Polymerase Location within the Gene.

Henderson HH, Timberlake KB, Austin ZA, Badani H, Sanford B, Tremblay K, Baird NL, Jones K, Rovnak J, Frietze S, Gilden D, Cohrs RJ.

J Virol. 2015 Nov 11;90(3):1231-43. doi: 10.1128/JVI.02617-15. Print 2016 Feb 1.

7.

Inhibition of cdk9 during herpes simplex virus 1 infection impedes viral transcription.

Ou M, Sandri-Goldin RM.

PLoS One. 2013 Oct 18;8(10):e79007. doi: 10.1371/journal.pone.0079007. eCollection 2013.

8.

The intracellular DNA sensor IFI16 gene acts as restriction factor for human cytomegalovirus replication.

Gariano GR, Dell'Oste V, Bronzini M, Gatti D, Luganini A, De Andrea M, Gribaudo G, Gariglio M, Landolfo S.

PLoS Pathog. 2012 Jan;8(1):e1002498. doi: 10.1371/journal.ppat.1002498. Epub 2012 Jan 26.

9.

Negative elongation factor is required for the maintenance of proviral latency but does not induce promoter-proximal pausing of RNA polymerase II on the HIV long terminal repeat.

Jadlowsky JK, Wong JY, Graham AC, Dobrowolski C, Devor RL, Adams MD, Fujinaga K, Karn J.

Mol Cell Biol. 2014 Jun;34(11):1911-28. doi: 10.1128/MCB.01013-13. Epub 2014 Mar 17.

10.

Repression of host RNA polymerase II transcription by herpes simplex virus type 1.

Spencer CA, Dahmus ME, Rice SA.

J Virol. 1997 Mar;71(3):2031-40.

12.

The role of ATF in regulating the human cytomegalovirus DNA polymerase (UL54) promoter during viral infection.

Kerry JA, Priddy MA, Staley TL, Jones TR, Stenberg RM.

J Virol. 1997 Mar;71(3):2120-6.

13.
14.

Human cytomegalovirus pUL29/28 and pUL38 repression of p53-regulated p21CIP1 and caspase 1 promoters during infection.

Savaryn JP, Reitsma JM, Bigley TM, Halligan BD, Qian Z, Yu D, Terhune SS.

J Virol. 2013 Mar;87(5):2463-74. doi: 10.1128/JVI.01926-12. Epub 2012 Dec 12.

15.

Human cytomegalovirus protein pUL117 targets the mini-chromosome maintenance complex and suppresses cellular DNA synthesis.

Qian Z, Leung-Pineda V, Xuan B, Piwnica-Worms H, Yu D.

PLoS Pathog. 2010 Mar 19;6(3):e1000814. doi: 10.1371/journal.ppat.1000814.

16.

Gene-specific requirement for P-TEFb activity and RNA polymerase II phosphorylation within the p53 transcriptional program.

Gomes NP, Bjerke G, Llorente B, Szostek SA, Emerson BM, Espinosa JM.

Genes Dev. 2006 Mar 1;20(5):601-12.

17.

Regulation of CCAAT/enhancer-binding protein (C/EBP) α in human-cytomegalovirus-infected fibroblasts.

Lee J, Kim S.

Arch Virol. 2016 May;161(5):1151-8. doi: 10.1007/s00705-016-2768-0. Epub 2016 Jan 30.

PMID:
26831934
18.

A temporal gate for viral enhancers to co-opt Toll-like-receptor transcriptional activation pathways upon acute infection.

Kropp KA, Hsieh WY, Isern E, Forster T, Krause E, Brune W, Angulo A, Ghazal P.

PLoS Pathog. 2015 Apr 9;11(4):e1004737. doi: 10.1371/journal.ppat.1004737. eCollection 2015 Apr.

19.
20.

Supplemental Content

Support Center